Drug application

M.V.I. PEDIATRIC (ASCORBIC ACID, BIOTIN, CYANOCOBALAMIN and 10 more)

Drugs@FDA NDA 018920 · HOSPIRA

Key facts

Drug name M.V.I. PEDIATRIC
Active ingredients ASCORBIC ACID, BIOTIN, CYANOCOBALAMIN, DEXPANTHENOL, ERGOCALCIFEROL, FOLIC ACID, NIACINAMIDE, PHYTONADIONE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN 5'-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, VITAMIN A and 1 more
Application type NDA
Application number 018920
Company HOSPIRA
Dosage forms FOR SOLUTION, INTRAVENOUS
Strength 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
Marketing status Discontinued
Reference listed drug Yes
Latest submission class Type 4 - New Combination
Latest submission status date Apr 6, 1983

At a glance

  • 1–9 Submissions
  • 10–99 Supplements
  • 1–9 Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date:

Browse all Drugs@FDA applications